China Universal Asset Management Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Sell |
44,265
-4,601
| -9% | -$2.05M | 1.85% | 9 |
|
|
2025
Q1 | $23.7M | Sell |
48,866
-3,515
| -7% | -$1.7M | 2.2% | 8 |
|
|
2024
Q4 | $21.1M | Buy |
52,381
+2,962
| +6% | +$1.19M | 1.97% | 8 |
|
|
2024
Q3 | $23M | Buy |
49,419
+14,564
| +42% | +$6.77M | 2.53% | 7 |
|
|
2024
Q2 | $16.3M | Sell |
34,855
-16,217
| -32% | -$7.6M | 2.3% | 8 |
|
|
2024
Q1 | $21.3M | Buy |
51,072
+12,985
| +34% | +$5.43M | 2.71% | 5 |
|
|
2023
Q4 | $15.5M | Buy |
38,087
+16,919
| +80% | +$6.88M | 3.02% | 3 |
|
|
2023
Q3 | $7.36M | Buy |
21,168
+3,353
| +19% | +$1.17M | 2.13% | 7 |
|
|
2023
Q2 | $6.27M | Buy |
17,815
+101
| +0.6% | +$35.5K | 1.94% | 10 |
|
|
2023
Q1 | $5.58M | Buy |
17,714
+928
| +6% | +$292K | 1.89% | 11 |
|
|
2022
Q4 | $4.85M | Sell |
16,786
-6,673
| -28% | -$1.93M | 1.95% | 11 |
|
|
2022
Q3 | $6.79M | Sell |
23,459
-970
| -4% | -$281K | 2.86% | 5 |
|
|
2022
Q2 | $6.88M | Sell |
24,429
-7,610
| -24% | -$2.14M | 2.89% | 8 |
|
|
2022
Q1 | $8.36M | Buy |
32,039
+32,024
| +213,493% | +$8.36M | 2.96% | 9 |
|
|
2021
Q4 | $3K | Buy |
+15
| New | +$3K | ﹤0.01% | 91 |
|